Cancer Cell Diagnostics (CCDx) Debuts Whole-Cell Genomic Profiling to Redefine Liquid Biopsy
JUPITER, Fla.--(BUSINESS WIRE)--Jul 22, 2026-- Cancer Cell Diagnostics today announced the commercial launch of its CellSight™ DNA comprehensive genomic profiling test. This test is built on a fundamentally distinct source material from conventional liquid …